Minerva Neurosciences (NERV) Reports Q3 Loss of $0.28
Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.28), versus $0.00 reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.
